In a significant advancement for cancer treatment, Brenus Pharma has announced the successful completion of a $25 million Series A financing round, aimed at accelerating the development of its precision cancer vaccines. This round was led by a consortium of French investors, in partnership with Belgian investment funds, and will primarily fund the first Phase…
Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a leader in the development of cutting-edge bacteriophage therapies, has been awarded an additional $5.25 million in non-dilutive funding by the U.S. Department of Defense (DoD). This significant grant, facilitated through the Medical Technology Enterprise Consortium (MTEC) and managed by the Naval Medical Research Command (NMRC) and the Joint…
MediWound Ltd. (Nasdaq: MDWD), a leader in enzymatic therapeutics for tissue repair, has announced a major funding milestone through the European Innovation Council (EIC) Accelerator program. The company has been awarded €16.25 million to propel the clinical development of EscharEx®, a groundbreaking biologic aimed at treating diabetic foot ulcers (DFUs). The EIC’s decision to support…
